1. ATRIAL FIBRILLATIONDr SYED RAZA MD,MRCP(UK),CCT(UK),MESC,Dip.Card(UK),FCCPConsultant Cardiologist 2. OBJECTIVES• Introduction• Classification• Burden of the problem•…

1. Type II DM andAntidiabetes AgentsCosts 2. Cost of Anti-diabetesAgents• Dramatic variation in daily costs• Recent introduction of newer agents (more costly)ODBF 2012…

Slide 1Saturday, April 13, 2013 Sharon L. Balkenhol, RN, MSN, CNS, APN Manager, Pulmonary Rehabilitation Jewish Hospital, Cincinnati, Ohio Slide 2 What is Pulmonary Rehabilitation…

Slide 1Whats new in EP? Say no to drugs? Lionel Faitelson MD FACC FHRS Tucson Heart Group TMC Cardiovascular Symposium 2012 Slide 2 New devices for arrhythmias? Anti-arrhythmic…

Slide 1Is There a Critical Value of Daily Atrial Tachyarrhythmia Burden from Device Diagnostics that Raises Stroke Risk? The TRENDS Study Taya V. Glotzer, Emile G. Daoud,…

Slide 1Epilepsy For the Non-Neurologist 2008 S. Andrew Josephson, MD Department of Neurology, Neurovascular Division University of California San Francisco Slide 2 Talk Like…

Slide 1Failure Prof. Nathan CLUMECK Head, Department of infectious diseases Saint-Pierre University Hospital Brussels, Belgium 6th EACS Advanced HIV Course Montpellier, Sept.…

Slide 1Management of Gout Dr Jennifer Hamilton Consultant Rheumatologist Queen Elizabeth Hospital Gateshead Slide 2 Overview Background Pathophysiology of gout Gateshead…

Slide 1Debbie L. Cardell, MD Div Gen Med UTHSCSA2/29/08 Anticoagulation Debbie L. Cardell, MD Asst. Clinical Prof of Medicine Medical Director UHC-D Anticoagulation Clinic…

Slide 1Echocardiographic Evaluation of Prosthetic Heart Valves Patricia Tung, M.D. February 10, 2010 Slide 2 Objectives  Types of prostheses  Prosthetic dysfunction…